Holland Die Condition Monitor - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Holland Die Condition Monitor


I Holland, the leading specialist manufacturer of tablet tooling for the pharmaceutical and nutraceutical industries, has recently launched the Holland Die Condition Monitor (HDCM).

HDCM is designed to monitor the condition of die bores, for any die type including multi-tips. When used at regular intervals it ensures that optimum life is achieved from dies and helps to prevent the production of damaged tablets.

A high accuracy probe is used, to measure the die bore wear (usually displayed  in the form of rings) and when used regularly it can help in the prediction  and planning of required expenditure on new die sets

HDCM can be fully integrated with I Holland’s Approve® system for a complete measurement solution, which incorporates tip diameter, barrel diameter, punch concentricity and die bore diameter.

When used as part of I Holland’s recommended PharmaCare® 7-Step Process, a professional punch and die maintenance and storage programme, HDCM assists punch and die users to ensure that critical tooling dimensions have stayed within tolerance following tool polishing or repair work, and helps to ensure proactive monitoring of tooling inventory.

 

I Holland

Website: www.iholland.co.uk

E-mail: clare.taylor@iholland.co.uk

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here